Fortress Biotech (FBIO) Income towards Parent Company: 2013-2025
Historic Income towards Parent Company for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $8.8 million.
- Fortress Biotech's Income towards Parent Company rose 133.03% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 36.67%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
- As of Q3 2025, Fortress Biotech's Income towards Parent Company stood at $8.8 million, which was up 124.62% from -$35.9 million recorded in Q2 2025.
- Fortress Biotech's Income towards Parent Company's 5-year high stood at $8.8 million during Q3 2025, with a 5-year trough of -$62.4 million in Q4 2021.
- In the last 3 years, Fortress Biotech's Income towards Parent Company had a median value of -$27.2 million in 2024 and averaged -$28.3 million.
- In the last 5 years, Fortress Biotech's Income towards Parent Company plummeted by 159.68% in 2021 and then surged by 133.03% in 2025.
- Fortress Biotech's Income towards Parent Company (Quarterly) stood at -$62.4 million in 2021, then rose by 7.88% to -$57.4 million in 2022, then spiked by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then spiked by 133.03% to $8.8 million in 2025.
- Its Income towards Parent Company was $8.8 million in Q3 2025, compared to -$35.9 million in Q2 2025 and -$21.8 million in Q1 2025.